Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 11/20 | 0.61 |
| ▸ | EGLN3 | Q9H6Z9 | 3/20 | 0.51 |
| ▸ | EGLN1 | Q9GZT9 | 6/20 | 0.47 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.47 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.45 |
| ▸ | ASPH | Q12797 | 1/20 | 0.45 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8247183 | 0.99 | HIF1A (0.62) | HIF1AEGLN3EGLN1EGLN2BBOX1 | |
| SCHEMBL8243641 | 0.95 | HIF1A (0.67) | HIF1AEGLN3EGLN1EGLN2BBOX1 | |
| SCHEMBL8237984 | 0.86 | HIF1A (0.68) | HIF1AEGLN1BBOX1ASPHKDM8 | |
| SCHEMBL8249796 | 0.82 | HIF1A (0.58) | HIF1AEGLN3EGLN1EGLN2 | |
| SCHEMBL5308270 | 0.81 | HIF1A (0.74) | HIF1AEGLN1BBOX1ASPHKDM8 | |
| SCHEMBL8245606 | 0.81 | HIF1A (0.56) | HIF1AEGLN3EGLN1EGLN2 | |
| SCHEMBL8248071 | 0.81 | HIF1A (0.56) | HIF1AEGLN3EGLN1 | |
| SCHEMBL8237955 | 0.81 | EGLN1 (0.64) | HIF1AEGLN3EGLN1 | |
| SCHEMBL5330885 | 0.80 | ALDH1A1 (0.56) | HIF1ANR1I2CYP2C9 | |
| SCHEMBL8248316 | 0.80 | HIF1A (0.55) | HIF1AEGLN3EGLN1EGLN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007038571-A2 | PROLYL HYDROXYLASE ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-04-05 | — | — | WO | disclosed |